Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
25
pubmed:dateCreated
2001-12-5
pubmed:abstractText
Although the growth factors that regulate megakaryocytopoiesis are well known, the molecular determinants of platelet formation from mature megakaryocytes remain poorly understood. Morphological changes in megakaryocytes associated with platelet formation and removal of senescent megakaryocytes are suggestive of an apoptotic process. Previously, we have established that nitric oxide (NO) can induce apoptosis in megakaryocytoid cell lines. To determine whether there is an association between NO-induced apoptosis and platelet production, we exposed Meg-01 cells to S-nitrosoglutathione (GSNO) with or without thrombopoeitin (TPO) pretreatment and used flow cytometry and electron microscopy to assess platelet-sized particle formation. Meg-01 cells treated with TPO alone produced few platelet-sized particles (<3% of total counts), whereas treatment with GSNO alone produced a significant percentage of platelet-sized particles (22 +/- 4% of total counts); when combined with TPO pretreatment, however, GSNO led to a marked increase in platelet-sized particle production (48 +/- 3% of total counts). Electron microscopy confirmed that Meg-01 cells treated with TPO and GSNO yielded platelet-sized particles with morphological features specific for platelet forms. The platelet-sized particle population appears to be functional, because addition of calcium, fibrinogen, and thrombin receptor-activating peptide led to aggregation. These results demonstrate that NO facilitates platelet production, thereby establishing the essential role of NO in megakaryocyte development and thrombopoiesis.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-10601342, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-10828028, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-2649185, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-2998511, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-505368, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-6821656, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-7164032, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-7774011, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-7909994, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-8583150, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-8608219, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-8759903, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-9015217, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-9066708, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-9292514, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-9345025, http://linkedlifedata.com/resource/pubmed/commentcorrection/11734646-9716588
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic GMP, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/NOS2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/NOS3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Donors, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type III, http://linkedlifedata.com/resource/pubmed/chemical/Nos2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Nos3 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/S-Nitrosoglutathione, http://linkedlifedata.com/resource/pubmed/chemical/Thrombopoietin
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
4
pubmed:volume
98
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14458-63
pubmed:dateRevised
2011-10-27
pubmed:meshHeading
pubmed-meshheading:11734646-Animals, pubmed-meshheading:11734646-Apoptosis, pubmed-meshheading:11734646-Blood Platelets, pubmed-meshheading:11734646-Cell Line, pubmed-meshheading:11734646-Cyclic GMP, pubmed-meshheading:11734646-Cytokines, pubmed-meshheading:11734646-Hematopoiesis, pubmed-meshheading:11734646-Humans, pubmed-meshheading:11734646-Megakaryocytes, pubmed-meshheading:11734646-Mice, pubmed-meshheading:11734646-Mice, Knockout, pubmed-meshheading:11734646-Microscopy, Electron, Scanning, pubmed-meshheading:11734646-Nitric Oxide, pubmed-meshheading:11734646-Nitric Oxide Donors, pubmed-meshheading:11734646-Nitric Oxide Synthase, pubmed-meshheading:11734646-Nitric Oxide Synthase Type II, pubmed-meshheading:11734646-Nitric Oxide Synthase Type III, pubmed-meshheading:11734646-S-Nitrosoglutathione, pubmed-meshheading:11734646-Thrombopoietin
pubmed:year
2001
pubmed:articleTitle
Induction of platelet formation from megakaryocytoid cells by nitric oxide.
pubmed:affiliation
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.